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Antibodies against 
Leptospira spp. in 
Captive Collared 
Peccaries, Peru
To the Editor: Leptospirosis is 
endemic to tropical South America 
and is a major public health problem 
for persons living in some regions 
of the Amazon Basin (1–3). For lo-
cal inhabitants, the collared peccary 
(Tayassu tajacu) represents  a major 
source of meat and income and is 
one of the most hunted species. As a 
result, several farms are attempting 
to produce captive collared peccaries 
(4). Although spirochetes have been 
isolated from bats, marsupials, and 
rodents in the Peruvian Amazon (5), 
local popular game animals have not 
been tested.
From May through December 
2003,  96 collared peccaries from 4 
experimental farms in 2 Amazonian 
provinces of Peru (Loreto and Ucay-
ali) were surveyed for antibodies 
against Leptospira spp. Although the 
initial stock of each farm came from 
the wild, most animals had been born 
in captivity, remained on their respec-
tive farms, and had no contact with an-
imals from the different farms. Blood 
samples were taken from animals that 
were born or maintained on the farm 
for ≥6 months, were in good physi-
cal condition, and showed no signs of 
disease. Samples that had been hemo-
lyzed or otherwise contaminated were 
discarded, leaving optimal samples 
from 96 animals (sex ratio 1:1, 71% 
>1 year of age).
The microscopic agglutination 
test was performed with a panel of 24 
antigens belonging to 17 serogroups 
of Leptospira spp. used for screening 
surveys at the National Leptospirosis 
Reference Laboratory. An additional 
distinct strain, obtained from a febrile 
human patient in the Peruvian Ama-
zon and provisionally designated as 
Var10, was added (2). Serum samples 
were considered positive if they had 
50% agglutination and titers >100 (6). 
Chi-square tests were used for statisti-
cal comparisons of sex and age; sig-
niﬁ  cance was set at p<0.05. 
Among the screened samples, 
64.6% reacted to 15 serovars (strains) 
that belong to 11 serogroups (Table). 
Seroprevalence did not differ signiﬁ  -
cantly in relation to sex or age. Var10 
was the most prevalent (56.2%) strain. 
This strain was isolated from a hu-
man patient in Iquitos (Loreto, Peru) 
and involved in recent outbreaks in 
the northern Peruvian Amazon (2); its 
taxonomic classiﬁ  cation is pending. In 
terms of its distribution, 32 peccaries 
had positive results for Var10 only; 
12 serum samples were reactive to 
>1 known serogroup. Leptospira sp. 
Var10 reacted mainly with serogroups 
Australis and Hebdomadis. Maxi-
mum titers were 6,400 for serogroup 
Tarassovi and 3,200 for Icterohaemor-
raghiae. High seroprevalence (15.6%) 
against serogroup Australis (serovar 
bratislava) has been reported in col-
lared peccaries and in feral and do-
mestic pigs (7,8)
Seroprevalence on the farm in Lo-
reto (n = 27) was 100%. At this farm, 
peccaries are kept near aquatic spe-
cies and numerous ponds of stagnant 
water, which provide an ideal envi-
ronment for the development of Lep-
tospira spp. Because of recent human 
leptospirosis outbreaks in the area (2), 
3 of the peccary caretakers were tested 
for antibodies against Leptospira spp.; 
their results were negative.
Although similar to animals de-
scribed in previous reports (7,9), 
none of the sampled animals showed 
evidence of disease at the time of sam-
pling; however, absence of clinical 
disease does not exclude the possibil-
ity of subclinical or past infections. 
Furthermore, the high prevalence of 
antibodies to multiple serotypes sug-
gests a wide exposure to Leptospira 
spp. Despite reports that suggest the 
collared peccary could act as a res-
ervoir for Leptospira spp. (7,9), the 
ﬁ  nding of high antibody titers in some 
individual animals could indicate that 
collared peccaries are incidental rath-
er than reservoir hosts. However, the 
prevalences found at 4 distant farms 
also indicate that this species could 
play some role in the maintenance and 
spread of leptospirosis in the Amazon 
Basin.
Multiple titers to different se-
rovars or serogroups in the same se-
rum sample are common with sero-
logic testing and difﬁ  cult to interpret. 
Multiple titers can result from cross-
reactions between different serovars 
or from true multiple infections (10). 
Regardless, serologic tests are only 
indicative of exposure to leptospires. 
Further efforts are necessary to isolate 
lepstospires from the urine or renal 
tissue of collared peccaries to con-
ﬁ  rm the presence of spirochetes and 
their  potential  dissemination  into  the        
environment.
Our ﬁ  ndings indicate that persons 
who have contact with collared pec-
caries and their products, particularly 
animal caretakers, researchers, hunt-
ers, and game traders, are at risk for LETTERS
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zoonotic disease (3). Because further 
wildlife production in the Peruvian 
Amazon is expected, movement of an-
imals and high animal densities could 
increase the chances of spirochete 
transmission within and between the 
farms. Therefore, precautions should 
be taken to limit the potential risks for 
leptospirosis transmission to domestic 
animals and humans.
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Table. Prevalence of antileptospiral agglutinins per positive serogroup in captive collared peccaries, Peruvian Amazon, May 2003–Dec 
2003*
Loreto area  Ucayali area 
BIOAM 
(n = 27) 
Pucallpa Natural 
Park (n = 6)  San Juan (n = 52) 
Club Divina 
Montaña (n = 11) 
Serogroup 
Positive
reactions
no. (%)  Max titer 
Positive
reactions
no. (%) 
Max  
titer
Positive
reactions
no. (%) 
Max 
titer
Positive
reactions
no. (%) 
Max 
titer
Positive
reactions
no. (%) 
Max 
titer
Total 62 (64.6)  6,400 27 (100)  6,400 1 (16.6)  100 27 (51.9)  3,200 7 (63.6)  100
Var10† 54 (56.2)  1,600 27 (100)  1,600 1 (16.6)  100 19 (36.5)  1,600 7 (63.6)  100
Australis 15 (15.6)  800 5 (18.5)  100 0 – 9 (17.3)  800 1 (9.1)  100
Hebdomadis 7 (7.3)  100 5 (18.5)  100 0 – 2 (3.8)  100 0 –
Icterohaemorrhagiae  4 (4.2)  3,200 2 (7.4)  100 0 – 2 (3.8)  3,200 0 –
Autumnalis 4 (4.2)  100 3 (11.1)  100 0 – 1 (1.9)  100 0 –
Bataviae 4 (4.2)  400 2 (7.4)  200 0 – 2 (3.8)  400 0 –
Tarassovi 3 (3.1)  6,400 3 (11.1)  6,400 0 – 0 – 0 –
Djasiman 2 (2.1)  800 0 – 0 – 2 (3.8)  800 0 –
Grippothyphosa  2 (2.1)  800 0 – 0 – 2 (3.8)  800 0 –
Ballum 2 (2.1)  100 2 (7.4)  100 0 – 0 – 0 –
Canicola 1 (1.0)  100 0 – 0 – 1 (1.9)  100 0 –
Mini 1 (1.0)  100 0 – 0 – 1 (1.9)  100 0 –
*BIOAM, Biodiversidad Amazónica; Max, maximum; –, titer not applicable.   
†Classification pending.  